Next Article in Journal
New Sperm Morphology Analysis in Equids: Trumorph® Vs Eosin-Nigrosin Stain
Previous Article in Journal
Anaplastic Mammary Carcinoma in Cat
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Veterinary Sciences
Volume 8
Issue 5
10.3390/vetsci8050078
vetsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach

by
Lola Llobat
Research Group Microbiological Agents Associated with Animal Reproduction (PROVAGINBIO), Department of Animal Production and Health, Veterinary Public Health and Food Science and Technology (PASAPTA) Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, 46113 Valencia, Spain
Vet. Sci. 2021, 8(5), 78; https://doi.org/10.3390/vetsci8050078
Submission received: 27 March 2021 / Revised: 27 April 2021 / Accepted: 2 May 2021 / Published: 4 May 2021
Browse Figures
Review Reports Versions Notes

Abstract

:
The regulation of early events in mammalian embryonic development is a complex process. In the early stages, pluripotency, cellular differentiation, and growth should occur at specific times and these events are regulated by different genes that are expressed at specific times and locations. The genes related to pluripotency and cellular differentiation, and growth factors that determine successful embryonic development are different (or differentially expressed) among mammalian species. Some genes are fundamental for controlling pluripotency in some species but less fundamental in others, for example, Oct4 is particularly relevant in bovine early embryonic development, whereas Oct4 inhibition does not affect ovine early embryonic development. In addition, some mechanisms that regulate cellular differentiation do not seem to be clear or evolutionarily conserved. After cellular differentiation, growth factors are relevant in early development, and their effects also differ among species, for example, insulin-like growth factor improves the blastocyst development rate in some species but does not have the same effect in mice. Some growth factors influence genes related to pluripotency, and therefore, their role in early embryo development is not limited to cell growth but could also involve the earliest stages of development. In this review, we summarize the differences among mammalian species regarding the regulation of pluripotency, cellular differentiation, and growth factors in the early stages of embryonic development.

1. Introduction

A successful pregnancy is a complex process that depends on different events that occur in an embryo and the maternal environment. At the preimplantation stages, sequential expression of specific genes in the embryo enable it to implant in the maternal endometrium, while failures in their expression or in their regulation cause pregnancy loss. Therefore, there are considerable differences between spatial and temporal transcriptomes and their regulatory pathways. After formation of the totipotent zygote, sequential cellular divisions occur and the morula is developed [1]. During the morula stage (until the 16-cell stage), the embryo is a compact sphere of cells where cell-to-cell tight junctions are first established [2]. Shortly after, the blastocyst stage is reached and two areas are differentiated: the inner cell mass (ICM), which is composed of the pluripotent epiblast (EPI) and hypoblast (HP) cells in the gastrula stage, and the trophectoderm (TE), which later forms the embryonic placenta. Blastocyst formation happens at different time points depending on the mammalian species. In mice, blastocyst formation occurs approximately 3 days post coitum; in rabbits and humans, it occurs around 3–6 days; in swine and horses, at 7 days; and in cattle and goats, around 7–8 days [3,4,5,6,7,8]. Finally, effective implantation takes place over a span of 6 days in pigs and 28 days in horses [9,10]. The precise genetic regulation of all these processes and their underlying molecular mechanisms are not conserved across species [1]. The differences between the time of embryonic development and implantation in mammal species are shown in Figure 1. Although these events occur at similar times in some species, the expression of certain transcription factors and growth factors vary. In other cases, the transcription factors and growth factors that have been found are the same, but their regulatory mechanisms and pathways differ between species. To extend the challenge of establishing pluripotent stem cells in domestic animals, it is necessary to understand the establishment of pluripotency and how growth factors influence early embryos. In this review, we focus on the most important factors that orchestrate early stages in embryonic development and their species-specific gene regulatory patterns.

2. Pluripotency Transcription Factors

One of the most critical transcription factors related to pluripotency and regulated by the Wnt canonical pathway in several mammals is the Oct4 transcription factor (belonging to the POU gene family, POU5F1 gene), which is expressed predominantly in pluripotent cells [14,15]. This transcription factor is necessary to maintain pluripotency, but its presence differs among species. In fact, Oct4 is expressed both in the ICM and TE in human, mouse, rabbit, pig, sheep, and cattle preimplantation embryos [4,8,16,17,18]; however, early development can be supported without Oct4 expression in bovines, so maternal Oct4 mRNA maintains its expression [19]. In goat embryos, the inhibition of Oct4 does not affect blastocyst formation but does increase the expression of other genes, such as Nanog homeobox (Nanog) [20]. The relative expression of Oct4 remains constant between the oocyte and morula stage, and decreases in blastocyst in in vitro studies, indicating the beginning of cellular differentiation. Factors such as Nanog and SRY-box transcription factor 2 (SOX2) are upregulated by the Wnt pathway in ICM around Day 8 in bovine embryos, with one (SOX2) or two (Nanog) characteristic peaks of expression in goat embryos at the 8- to 16-cell stage and later blastocyst stage, respectively. In this context, Nanog expression is necessary for the proliferation of TE cells [5,15,21,22,23].
Ozawa et al. [24] analyzed gene expression between the ICM and the TE in bovine embryos, and showed that Nanog and SOX2 presented similar expression patterns in bovine embryos obtained from mice and humans. Nanog expression was higher in ICM than TE in bovine expression, while Oct4 expression was similar, and Nanog is necessary for the expression of SOX2 (marker of EPI cells), GATA6 (marker of HP cells), and CDX2 [25]. Oct4, Nanog, and SOX2 expression in bovine embryos is regulated by the exogen bone morphogenetic protein 5 (BMP5) [26]. In human embryos, BMP5 and other BMPs regulate different sets of developmental genes, such as GATA2, GATA3, and CDX2, and BMP10 is the one with greater regulatory potential [27]. Recently, Naddafpour et al. [20] reported that Oct4 inhibition in goat embryos increased the relative expression of CDX2. This gene presents an important function in mouse embryos, since, after TE formation, it inhibits Oct4 expression in their cells and allows the differentiation of TE cells [28]. In fact, Oct4 is not required to inhibit CDX2 expression in bovine and human ICM, but is necessary for the expression of Nanog [19,29]. The molecular mechanism that maintains Nanog expression in the absence of Oct4 is still unknown in mice. Additionally, GATA6 expression is repressed by Oct4 to facilitate HP differentiation [30,31]. This inhibition in mice occurs by blocking the MEK/ERK pathway, which leads to GATA6 downregulation in HP and depends on the fibroblast growth factor (FGF) [32]. In humans, cattle, pigs, and rabbits, the segregation of HP is independent of FGF [33,34,35]. MEK inhibition reduces the number of HP cells in mice and rats, but not in humans, cattle, pigs, and rabbits [33].
Transcriptomic analyses of embryos from different species have identified additional regulatory factors that modulate pluripotency and cellular differentiation in early development. Bernardo et al. [36] compared pluripotency genes in mouse, pig, and bovine embryos and found that around 82% of the genes were commonly expressed across the three species studied. Regarding Oct4, Nanog, and SOX2 expression in the ICM, mice at Day 3.5 showed expression levels similar to those of cattle and pigs at Day 7, and three genes were upregulated between the transition from ICM to EPI in pigs and cattle, while Nanog and SOX2 were downregulated and Oct4 was stable in mice [33]. For example, bovine embryos upregulated 159 and 48 genes in the ICM and TE, respectively. Genes expressed differentially have been compared using gene ontology with mice and humans, and species-specific pluripotency control in ICM was demonstrated [37]. In pigs, analysis of individual cells by single-cell RNA sequencing showed expression of some species-specific genes, such as paired box 6 (PAX6), aquaporin 3 (AQP3), and in late blastocyst, clathrin adaptor protein (DAB2), platelet-derived growth factor receptor alpha (PDGFRA), fibronectin 1 (FN1), hepatocyte nuclear factor 4 alpha (HNF4F), goosecoid homeobox (GCS), nuclear receptor subfamily 5 group A member 2 (NR5A2), and lysine acetyl-transferase 6A (KAT6A) [38].
In summary, these findings indicate that although the control of pluripotency is mainly carried out through the canonical Wnt/β-catenin and MER/ERK pathways, downstream temporal and spatial development cues differ depending on the species.

3. Growth Factors and Early Development

3.1. Vascular Endothelial Growth Factor (VEGF)

Adhesion processes can be affected by growth factors that regulate vascularization and cellular motility. One of these factors, vascular endothelial growth factor (VEGF) is associated with de novo vascularization in a wide variety of processes, such as implantation, embryogenesis, menstrual cycle, corpus luteum development, ovarian follicular development, and tumorigenesis [39,40]. Initially, VEGF was characterized for its ability to induce vascularity, permeability, and promote vascular endothelial cell proliferation [41]. Three families of VEGF proteins and their corresponding receptors have been characterized and the main receptors involved in the first steps of signal transduction cascades comprise different tyrosine kinases receptors, such as VEGFR-1, VEGFR-2, and VEGFR-3 [42]. Across species, some VEGF family members and receptors are found in placentomes, uterus tissues, and oviduct, and in different species including humans, mice, rats, cattle, sheep, pigs, and rabbits [43,44,45,46,47,48,49,50]. The in vivo administration of VEGF to goats and sheep stimulates follicular growth and increases the number of preovulatory follicles [51]. Studies in vitro have shown that VEGF supplementation in bovine and pig embryo culture improves cytoplasmatic maturation and blastocyst development rates [52,53]. Recently, Liu et al., (2020) [54] showed that VEGF improved embryo development rates in vitro, on the one hand, through activation of the MAPK pathway and, on the other hand, via inhibition of the canonical Wnt pathway during the last step of oocyte maturation.
In the embryo, the expression of VEGF and its receptors (VEGFR-1 and VEGFR-2) are also conserved in different species. For example, VEGF expression has been related to fetal weight increase in porcine embryos [55], in which VEGF expression was detected in TE cells at Day 14 of pregnancy [50]. VEGF, VEGFR-1, and VEGFR-2 mRNA have been found in vitellin sacs and TEs of bovine embryos [49,56,57]. In humans, VEGF expression increases in the late luteal phase, while in bovine corpus luteum, VEGF mRNA is upregulated in the early luteal phase, and then is progressively downregulated until its levels increase again during pregnancy [58,59]. In rabbits, VEGF expression increases around Day 6 of pregnancy before implantation [8].
The role of VEGF in vascularization and fetal growth is known, but additional players are gaining biological relevance in successful embryonic development and implantation in mammals. For instance, a critical role of macrophage recruitment and embryo polarization have been reported [60].

3.2. Transforming Growth Factor-Beta (TGF-β) Superfamily

Another relevant group of growth factors that are conserved across species before and during implantation is the transforming growth factor-beta (TGF-β) superfamily. This superfamily comprises regulating factors involved in growth and differentiation, for example, bone morphogenetic proteins (BMPs), activin (Ac), nodal and gonadal hormone growth factors, as well as inhibin (In) [61]. In particular, Ac plays an important role in cellular differentiation, proliferation, and apoptosis [62]. Recently, Bloise et al. [63] published a review and provided an in-depth analyses of the different functions of activin in human reproduction. The authors described the different roles of Ac and highlighted its role promoting endovascular differentiation in TE through VEGF stimulation. In summary, Ac facilitates blastocyst union and TE penetration during the first stages of implantation in humans and mice. These roles of the TGF-β superfamily have also been demonstrated in other species, such as pigs, in which TGF-β regulates blastocyst differentiation and maturation events, including modulating the interaction between the uterus and embryo during implantation [64,65]. Another member of the TGF-β superfamily, growth differentiation factor-8 (DGF-8), is involved in the expression of ICM marker SOX2 during porcine embryo in in vitro development, indicating its role in preimplantation embryonic development and pluripotency control [66]. In fact, TGF-β expression increases in the porcine conceptus–maternal interface at the same time that the embryo is lengthened and the fixation and implantation process begins [67]. In in vitro culture, the addition of TGF-β superfamily factors, such as BMP-15, improves blastocyst development rates in sheep, goats, and cattle [5,68,69]. In fact, expression of TGF-β in early bovine embryos (from two- to eight-cell stages) has been shown to increase the relative abundance of Nanog, suggesting an early role of TGF-β [70]. In rabbits, the relative expression of TGF-β increases on Day 6 of pregnancy [8]; therefore, this early role of TGF-β could be species specific. The activity of the TGF-β superfamily members is mediated through SMAD signaling in humans and mice, and SMAD2 and SMAD3 are necessary for bovine early embryonic development [71,72]. The AKT pathway seems to play an important role; therefore, SMAD signaling might not be the only way to regulate TGF-β actions in bovine embryos [73].

3.3. Fibroblast Growth Factor (FGF) Family

The fibroblast growth factor (FGF) family members are involved in angiogenesis, embryonic development, and have a role in controlling peri-implantation development [74,75,76,77]. Some FGF family members, such as FGF-3 and FGF-8, are related to the differentiation of different tissues in the late stages of development, such as brain, liver, pancreas, and heart, among other organs and tissues in mammals [78,79,80,81,82,83].
In human and mouse embryos, FGF promotes mesoderm formation and proliferation [84,85]. Recently, Guzzeta et al. (2020) demonstrated that a Hedgehog–FGF signaling axis is required for anterior mesoderm lineage development during gastrulation [86]. In mouse blastocyst, the expression of the FGF-2 receptor is observed, but not in human blastocyst [87]. These data suggest that the expansion of TE in early development depends on FGF in mice, and that this expansion, which is dependent on FGF, occurs more in late stages in humans. The actions of FGF family members begin in the initial steps of reproduction mechanisms, therefore, FGF-10 expression has been detected in theca cells and ovarian stromal cells in humans [88], and FGF-2 and FGF-10 have been shown to increase the survival and proliferation of cumulus cells, increasing blastocyst development rates in bovine, sheep, and yak, in in vitro cultures [89,90,91,92]. Another family member, FGF-18, seems to regulate steroidogenesis in the fetal ovary [93]. In the early development of bovine embryos, FGF-2 regulates the expression of genes related to the development and proliferation of ICM, such as Nanog and GATA6 [94]. In addition, FGF-1, FGF-2, and FGF-10 produced by TE control the expression of interferon tau (IFN-τ), favoring implantation in cows [75]. FGF family members also play an important role in the early development of pig embryos. FGF-4 regulates TE formation and elongation [95], and the amount of FGF-2 increases in endometrial tissues between Days 15 and 20 of pregnancy, demonstrating its relevance in embryo elongation and implantation [45]. The mechanisms by which FGF family members regulate all these events, and which are the most relevant factors in each species, remain unknown. Table 1 summarizes the more important FGF family members related to reproduction events, localization, and the species in which they are found.

3.4. Insulin-Like Growth Factor (IGF) System

Insulin-like growth factors (IGFs) are polypeptides with insulin-like sequences with mitogenic properties that induce proliferation and growth of somatic cells [106]. In addition, fetal and placental growth are regulated by autocrine and paracrine IGFs and their receptors, such as insulin-like growth factor receptor 1 (IGFR-1), insulin-like growth factor receptor 2 (IGFR-2), and insulin receptor (IR) in humans and mice [107]. IGFR-1 is an IR-like tetrameric transmembrane protein with high affinity to IGF-1 and IGF-2 [108,109]. IGFR-2 is a simplex polypeptide with affinity only to IGF-2 [110].
IGF-1 and IGF-2 have been correlated to fetal, placental, and post-partum growth in different species of mammals, including humans, rodents, cattle, sheep, pigs, and dogs [111,112,113,114,115]. In vitro and in vivo studies have shown placental and fetal growth regulation by autocrine and paracrine effect of IGF-1 and IGF-2, and their interactions with IGFR-1, IGFR-2, and IR [107]. These factors and their receptors do not only influence fetal and placental growth but also regulate different signaling cascades to promote cellular proliferation and differentiation in some reproductive steps [116,117]. In fact, IGF-2, IGFR-1, IGFR-2, and IR are present in human and mouse oocytes, where an IGF/insulin axis regulates gamete development [118,119]. This regulation differs between species, e.g., rat oocytes only express IGF-1 but not its receptor IGFR-1 [120], bovine oocytes express two receptors, IGFR-1 and IGFR-2, and IGF-1 but not IGF-2 [121,122], and in dog, corpus luteum presents a similar amount of IGFR-1, but expression of IGF-1 diminishes during embryonic development [123]. In vitro studies have shown that the addition of IGF-1 in culture oocyte medium improves maturation rate and embryonic development in sheep by the PI3/AKT pathways, but the blastocyst development rate is not affected in sheep and mice [124,125,126]. The PI3K/AKT pathway is activated by IGF-1 and IGFR-1, and IR is secreted in early human embryos, whereas this pathway is activated by IGF-1 in the trophectoderm of horses [127,128]. In fact, IGF-1 and IGF-2 are expressed by blastocyst in several mammalian species (Table 2) [48,119,128,129,130,131].
Indeed, the addition of IGF-1 in culture medium activates the PI3K/AKT pathway and improves blastocyst development rates in humans, cattle, goats, yaks, and horses but not in mice and sheep [124,127,128,152,153,154,155]. Similar results have been observed with the addition of IGF-2 in humans and cattle [156,157]. These results indicate that the IGF system is related to placental, fetal, and postnatal growth in mammals and is also involved in the process of cellular differentiation in early embryos. In fact, interactions between IGF-2 and IGFR-2 have been shown to regulate homeobox genes controlling apoptosis in human and bovine TE cells [157,158]. Studies in yak early embryos have shown that the addition of IGF-1 increased Bcl-2 expression (anti-apoptotic gene) and diminished Bax expression (apoptotic gene), therefore, this regulation of apoptotic events occurs by different compounds of the IGF system depending on the species [153]. A schematic of the canonical pathway of apoptosis regulation by the IGF system is shown in Figure 2.
Differences in IGF system control such as the fact that the addition of IGF-1 in culture medium improves blastocyst development rates in some species but not in mice, or IGFR-2 expression in some mammalian blastocysts but not in mice and sheep, indicate relevant alternative pathways of regulation by the IGF system. These results suggest that it would be interesting to use species other than mice, such as bovine or rabbit, for the study of human embryonic development.

3.5. Epidermal Growth Factor (EGF) Family

The epidermal growth factor (EGF) family comprises 13 polypeptide proteins that bind to members of the four ErbB family receptors. These four receptors have the ability to bind different growth factors and molecules, and regulate different events such as cell proliferation, migration, differentiation, and apoptosis [159]. Regarding reproductive events, the best-known roles of EGF are in oocyte growth, maturation, and developmental competence in mammals [160]. In cows, da Rosa et al. [161] demonstrated that inhibition of EGF receptors arrested oocyte development in the germinal vesicle stage, and Sugimura et al. [162] determined that EGF was necessary to correct oocyte–cumulus communication. Supplementation of medium with EGF increased oocyte maturation in goats, whereas this improvement in oocyte maturation did not occur in pigs [163,164]. The results in early embryos have been contradictory according to the species and the study. For example, in bovine embryos, in vitro culture supplementation of EGF and insulin-transferrin-sodium selenite (a common complement for the in vitro culture), increased the embryonic development rate and TE capacity of invasion [165]. In contrast with these results, Dall’Acqua et al. [166] did not observe differences in blastocyst development rate in in vitro culture with EGFR inhibitor, and they observed decreased apoptosis in early embryos. These results could indicate that EGF alone does not improve blastocyst development in cattle. Kelly et al. [155] found similar results in sheep; however, EGF seems to improve embryo in vitro production in mice, goats, and pigs [155,163,167,168].
Some studies have demonstrated EGF and its receptors’ expression in the early embryos of mice, rabbits, sheep, and pigs, but this expression does not exist in other mammals, such as goats [48,169,170,171,172]. These data suggest that EGF has a role in embryonic development that is species specific, although further studies are necessary to discover this role and its mechanisms.

3.6. Other Growth Factors

In addition to the growth factors previously analyzed in this review, other factors that affect early embryonic development and oocyte development have been found in different mammalian species. For example, nerve growth factor (NGF) has a role in embryonic development in sheep and oocyte development in rabbits [173,174]; growth factor receptor-bound protein 10 (GRB10) plays a role in embryonic development in humans and cattle [175,176]; hepatoma-derived growth factor (HDGF) promotes early blastocyst development without bovine serum albumin (BSA) [177]; hepatocyte growth factor activator inhibitor-1 (HAI-1) is necessary for human and murine TE function [178,179]; granulocyte–macrophage colony-stimulating factor (GMCSF) is secreted from cells of the female reproductive tract in mice, accelerating the development of the blastocyst in vitro, and the presence of this growth factor is related to the high proliferation and viability of blastomeres [180]; and platelet-derived growth factor (PDGF) increases the development of bovine and human embryos after the 16-cell stage and morula stage [181,182,183]. In vitro studies have demonstrated an increase in human blastocyst development rate via supplementation with other growth factors such as brain-derived neurotrophic factor (BNF), glial cell-line derived neurotrophic factor (GCLDNF), and colony-stimulating factor (CSF) [183] that reduce oocyte competence and exert a positive effect in Nanog and SOX2 expression in bovine epiblast [184].
In summary, a large number of growth factors are related to embryonic development, and there is still much to be investigated with regard to the roles they play during development in different species of mammals.

4. Conclusions

During early embryonic development in mammals, several cellular and molecular mechanisms are activated, each involving different transcription factors and growth factors, related to pluripotency control, and cellular differentiation and growth. Some of these events, however, are species-specific. Therefore, the interaction of these factors with each other, and the metabolic pathways involved remain to be clarified. The use of certain species, such as the mouse, to understand these mechanisms in early pregnancy in humans should be reviewed since substantial differences between the two species are evident. In addition, many questions about regulator genes of pluripotency and cellular differentiation, and other molecules, such as growth factors as well as the interactions among them in different mammalian species, remain to be answered.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Acknowledgments

I am grateful to the Veterinary Medicine Faculty at the Universidad Cardenal Herrera CEU.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Madeja, Z.E.; Pawlak, P.; Piliszek, A. Beyond the Mouse: Non-Rodent Animal Models for Study of Early Mammalian Development and Biomedical Research. Int. J. Dev. Biol. 2019, 63, 187–201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Lonergan, P.; Fair, T.; Forde, N.; Rizos, D. Embryo Development in Dairy Cattle. Theriogenology 2016, 86, 270–277. [Google Scholar] [CrossRef]
  3. Flood, P.F.; Betteridge, K.J.; Diocee, M.S. Transmission Electron Microscopy of Horse Embryos 3-16 Days after Ovulation. J. Reprod. Fertil. Suppl. 1982, 32, 319–327. [Google Scholar] [PubMed]
  4. Hall, V.J. Early Development of the Porcine Embryo: The Importance of Cell Signalling in Development of Pluripotent Cell Lines. Reprod. Fertil. Dev. 2012, 25, 94–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. HosseinNia, P.; Hajian, M.; Tahmoorespur, M.; Hosseini, S.M.; Ostadhosseini, S.; Nasiri, M.R.; Nasr-Esfahani, M.H. Expression Profile of Developmentally Important Genes in Preand Peri-Implantation Goat Embryos Produced In Vitro. Int. J. Fertil. Steril. 2016, 10, 310–319. [Google Scholar] [CrossRef] [PubMed]
  6. Mclaren, A.; Smith, R. Functional Test of Tight Junctions in the Mouse Blastocyst. Nature 1977, 267, 351–353. [Google Scholar] [CrossRef]
  7. Niakan, K.K.; Eggan, K. Analysis of Human Embryos from Zygote to Blastocyst Reveals Distinct Gene Expression Patterns Relative to the Mouse. Dev. Biol. 2013, 375, 54–64. [Google Scholar] [CrossRef] [Green Version]
  8. Saenz-de-Juano, M.D.; Peñaranda, D.S.; Marco-Jiménez, F.; Llobat, L.; Vicente, J.S. Differential MRNA Expression in Rabbit in Vivo Pre-Implantatory Embryos. Reprod. Domest. Anim. 2011, 46, 567–572. [Google Scholar] [CrossRef]
  9. Bazer, F.W.; Johnson, G.A. Pig Blastocyst-Uterine Interactions. Differentiation 2014, 87, 52–65. [Google Scholar] [CrossRef]
  10. Stout, T.A.E.; Meadows, S.; Allen, W.R. Stage-Specific Formation of the Equine Blastocyst Capsule Is Instrumental to Hatching and to Embryonic Survival in Vivo. Anim. Reprod. Sci. 2005, 87, 269–281. [Google Scholar] [CrossRef]
  11. Piliszek, A.; Madeja, Z.E. Pre-Implantation Development of Domestic Animals. Curr. Top. Dev. Biol. 2018, 128, 267–294. [Google Scholar] [CrossRef] [PubMed]
  12. Brinster, R.L. Embryo Development. J. Anim. Sci. 1974, 38, 1003–1012. [Google Scholar] [CrossRef] [PubMed]
  13. Simmet, K.; Zakhartchenko, V.; Wolf, E. Comparative Aspects of Early Lineage Specification Events in Mammalian Embryos—Insights from Reverse Genetics Studies. Cell Cycle 2018, 17, 1688–1695. [Google Scholar] [CrossRef] [Green Version]
  14. Boyer, L.A.; Mathur, D.; Jaenisch, R. Molecular Control of Pluripotency. Curr. Opin. Genet. Dev. 2006, 16, 455–462. [Google Scholar] [CrossRef] [PubMed]
  15. Madeja, Z.E.; Hryniewicz, K.; Orsztynowicz, M.; Pawlak, P.; Perkowska, A. WNT/β-Catenin Signaling Affects Cell Lineage and Pluripotency-Specific Gene Expression in Bovine Blastocysts: Prospects for Bovine Embryonic Stem Cell Derivation. Stem Cells Dev. 2015, 24, 2437–2454. [Google Scholar] [CrossRef]
  16. Degrelle, S.A.; Campion, E.; Cabau, C.; Piumi, F.; Reinaud, P.; Richard, C.; Renard, J.-P.; Hue, I. Molecular Evidence for a Critical Period in Mural Trophoblast Development in Bovine Blastocysts. Dev. Biol. 2005, 288, 448–460. [Google Scholar] [CrossRef] [Green Version]
  17. Silva, P.G.C.; Moura, M.T.; Silva, R.L.O.; Nascimento, P.S.; Silva, J.B.; Ferreira-Silva, J.C.; Cantanhêde, L.F.; Chaves, M.S.; Benko-Iseppon, A.M.; Oliveira, M.A.L. Temporal Expression of Pluripotency-Associated Transcription Factors in Sheep and Cattle Preimplantation Embryos. Zygote 2018, 26, 270–278. [Google Scholar] [CrossRef]
  18. Van Eijk, M.J.; van Rooijen, M.A.; Modina, S.; Scesi, L.; Folkers, G.; van Tol, H.T.; Bevers, M.M.; Fisher, S.R.; Lewin, H.A.; Rakacolli, D.; et al. Molecular Cloning, Genetic Mapping, and Developmental Expression of Bovine POU5F1. Biol. Reprod. 1999, 60, 1093–1103. [Google Scholar] [CrossRef] [Green Version]
  19. Simmet, K.; Zakhartchenko, V.; Philippou-Massier, J.; Blum, H.; Klymiuk, N.; Wolf, E. OCT4/POU5F1 Is Required for NANOG Expression in Bovine Blastocysts. Proc. Natl. Acad. Sci. USA 2018, 115, 2770–2775. [Google Scholar] [CrossRef] [Green Version]
  20. Naddafpour, A.; Ghazvini Zadegan, F.; Hajian, M.; Hosseini, S.M.; Jafarpour, F.; Rahimi, M.; Habibi, R.; Nasr Esfahani, M.H. Effects of Abundances of OCT-4 MRNA Transcript on Goat Pre-Implantation Embryonic Development. Anim. Reprod. Sci. 2020, 215, 106286. [Google Scholar] [CrossRef]
  21. Habibi, R.; Hosseini, S.M.; Zadegan, F.G.; Hajian, M.; Ostadhosseini, S.; Vash, N.T.; Naddafpour, A.; Nasr Esfahani, M.H. Functional Characterization of NANOG in Goat Pre-Implantation Embryonic Development. Theriogenology 2018, 120, 33–39. [Google Scholar] [CrossRef]
  22. Kumar, D.; Sarkhel, B.C. Differential Expression Pattern of Key Regulatory Developmental Genes in Pre-Implant Zona Free Cloned vs. in Vitro Fertilized Goat Embryos. Gene Expr. Patterns 2017, 25–26, 118–123. [Google Scholar] [CrossRef]
  23. Llobat, L. Embryo Gene Expression in Pig Pregnancy. Reprod. Domest. Anim. 2020. [Google Scholar] [CrossRef] [PubMed]
  24. Ozawa, M.; Sakatani, M.; Yao, J.; Shanker, S.; Yu, F.; Yamashita, R.; Wakabayashi, S.; Nakai, K.; Dobbs, K.B.; Sudano, M.J.; et al. Global Gene Expression of the Inner Cell Mass and Trophectoderm of the Bovine Blastocyst. BMC Dev. Biol 2012, 12, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Ortega, M.S.; Kelleher, A.M.; O’Neil, E.; Benne, J.; Cecil, R.; Spencer, T.E. NANOG Is Required to Form the Epiblast and Maintain Pluripotency in the Bovine Embryo. Mol. Reprod. Dev. 2020, 87, 152–160. [Google Scholar] [CrossRef]
  26. García, E.V.; Miceli, D.C.; Rizo, G.; Valdecantos, P.A.; Barrera, A.D. Effect of Early Addition of Bone Morphogenetic Protein 5 (BMP5) to Embryo Culture Medium on in Vitro Development and Expression of Developmentally Important Genes in Bovine Preimplantation Embryos. Theriogenology 2015, 84, 589–599. [Google Scholar] [CrossRef] [PubMed]
  27. Lichtner, B.; Knaus, P.; Lehrach, H.; Adjaye, J. BMP10 as a Potent Inducer of Trophoblast Differentiation in Human Embryonic and Induced Pluripotent Stem Cells. Biomaterials 2013, 34, 9789–9802. [Google Scholar] [CrossRef]
  28. Berg, D.K.; Smith, C.S.; Pearton, D.J.; Wells, D.N.; Broadhurst, R.; Donnison, M.; Pfeffer, P.L. Trophectoderm Lineage Determination in Cattle. Dev. Cell 2011, 20, 244–255. [Google Scholar] [CrossRef] [Green Version]
  29. Fogarty, N.M.E.; McCarthy, A.; Snijders, K.E.; Powell, B.E.; Kubikova, N.; Blakeley, P.; Lea, R.; Elder, K.; Wamaitha, S.E.; Kim, D.; et al. Genome Editing Reveals a Role for OCT4 in Human Embryogenesis. Nature 2017, 550, 67–73. [Google Scholar] [CrossRef]
  30. Kuijk, E.W.; van Tol, L.T.A.; Van de Velde, H.; Wubbolts, R.; Welling, M.; Geijsen, N.; Roelen, B.A.J. The Roles of FGF and MAP Kinase Signaling in the Segregation of the Epiblast and Hypoblast Cell Lineages in Bovine and Human Embryos. Development 2012, 139, 871–882. [Google Scholar] [CrossRef] [Green Version]
  31. Piliszek, A.; Madeja, Z.E.; Plusa, B. Suppression of ERK Signalling Abolishes Primitive Endoderm Formation but Does Not Promote Pluripotency in Rabbit Embryo. Development 2017, 144, 3719–3730. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Plusa, B.; Piliszek, A.; Frankenberg, S.; Artus, J.; Hadjantonakis, A.-K. Distinct Sequential Cell Behaviours Direct Primitive Endoderm Formation in the Mouse Blastocyst. Development 2008, 135, 3081–3091. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Bontovics, B.; Maraghechi, P.; Lázár, B.; Anand, M.; Németh, K.; Fábián, R.; Vašíček, J.; Makarevich, A.V.; Gócza, E.; Chrenek, P. The Effect of Dual Inhibition of Ras-MEK-ERK and GSK3β Pathways on Development of in Vitro Cultured Rabbit Embryos. Zygote 2020, 28, 183–190. [Google Scholar] [CrossRef] [PubMed]
  34. Rodríguez, A.; Allegrucci, C.; Alberio, R. Modulation of Pluripotency in the Porcine Embryo and IPS Cells. PLoS ONE 2012, 7, e49079. [Google Scholar] [CrossRef]
  35. Roode, M.; Blair, K.; Snell, P.; Elder, K.; Marchant, S.; Smith, A.; Nichols, J. Human Hypoblast Formation is Not Dependent on FGF Signalling. Dev. Biol. 2012, 361, 358–363. [Google Scholar] [CrossRef] [Green Version]
  36. Bernardo, A.S.; Jouneau, A.; Marks, H.; Kensche, P.; Kobolak, J.; Freude, K.; Hall, V.; Feher, A.; Polgar, Z.; Sartori, C.; et al. Mammalian Embryo Comparison Identifies Novel Pluripotency Genes Associated with the Naïve or Primed State. Biol. Open 2018, 7. [Google Scholar] [CrossRef] [Green Version]
  37. Zhao, X.-M.; Cui, L.-S.; Hao, H.-S.; Wang, H.-Y.; Zhao, S.-J.; Du, W.-H.; Wang, D.; Liu, Y.; Zhu, H.-B. Transcriptome Analyses of Inner Cell Mass and Trophectoderm Cells Isolated by Magnetic-Activated Cell Sorting from Bovine Blastocysts Using Single Cell RNA-Seq. Reprod. Domest. Anim. 2016, 51, 726–735. [Google Scholar] [CrossRef]
  38. Wei, Q.; Li, R.; Zhong, L.; Mu, H.; Zhang, S.; Yue, L.; Xiang, J.; Li, E.; Zhi, M.; Cao, S.; et al. Lineage Specification Revealed by Single-Cell Gene Expression Analysis in Porcine Preimplantation Embryos. Biol. Reprod. 2018, 99, 283–292. [Google Scholar] [CrossRef] [Green Version]
  39. Ferrara, N.; Chen, H.; Davis-Smyth, T.; Gerber, H.P.; Nguyen, T.N.; Peers, D.; Chisholm, V.; Hillan, K.J.; Schwall, R.H. Vascular Endothelial Growth Factor Is Essential for Corpus Luteum Angiogenesis. Nat. Med. 1998, 4, 336–340. [Google Scholar] [CrossRef]
  40. Valdés, G.; Erices, R.; Chacón, C.; Corthorn, J. Angiogenic, Hyperpermeability and Vasodilator Network in Utero-Placental Units along Pregnancy in the Guinea-Pig (Cavia Porcellus). Reprod. Biol. Endocrinol. 2008, 6, 13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Ferrara, N. Vascular Endothelial Growth Factor: Molecular and Biological Aspects. Curr. Top. Microbiol. Immunol. 1999, 237, 1–30. [Google Scholar] [CrossRef]
  42. Yancopoulos, G.D.; Davis, S.; Gale, N.W.; Rudge, J.S.; Wiegand, S.J.; Holash, J. Vascular-Specific Growth Factors and Blood Vessel Formation. Nature 2000, 407, 242–248. [Google Scholar] [CrossRef] [PubMed]
  43. Cheung, C.Y.; Anderson, D.F.; Brace, R.A. Transport-Associated Pathway Responses in Ovine Fetal Membranes to Changes in Amniotic Fluid Dynamics. Physiol. Rep. 2017, 5, e13455. [Google Scholar] [CrossRef] [PubMed]
  44. Gabler, C.; Einspanier, A.; Schams, D.; Einspanier, R. Expression of Vascular Endothelial Growth Factor (VEGF) and Its Corresponding Receptors (Flt-1 and Flk-1) in the Bovine Oviduct. Mol. Reprod. Dev. 1999, 53, 376–383. [Google Scholar] [CrossRef]
  45. Kaczynski, P.; Goryszewska, E.; Baryla, M.; Waclawik, A. Prostaglandin F2α Stimulates Angiogenesis at the Embryo-Maternal Interface during Early Pregnancy in the Pig. Theriogenology 2019, 142, 169–176. [Google Scholar] [CrossRef]
  46. Kalkunte, S.S.; Mselle, T.F.; Norris, W.E.; Wira, C.R.; Sentman, C.L.; Sharma, S. Vascular Endothelial Growth Factor C Facilitates Immune Tolerance and Endovascular Activity of Human Uterine NK Cells at the Maternal-Fetal Interface. J. Immunol. 2009, 182, 4085–4092. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Kazi, A.A.; Koos, R.D. Estrogen-Induced Activation of Hypoxia-Inducible Factor-1alpha, Vascular Endothelial Growth Factor Expression, and Edema in the Uterus Are Mediated by the Phosphatidylinositol 3-Kinase/Akt Pathway. Endocrinology 2007, 148, 2363–2374. [Google Scholar] [CrossRef] [PubMed]
  48. Llobat, L.; Marco-Jiménez, F.; Peñaranda, D.S.; Thieme, R.; Navarrete, A.; Vicente, J.S. MRNA Expression in Rabbit Blastocyst and Endometrial Tissue of Candidate Gene Involved in Gestational Losses. Reprod. Domest. Anim. 2012, 47, 281–287. [Google Scholar] [CrossRef]
  49. Pfarrer, C.D.; Ruziwa, S.D.; Winther, H.; Callesen, H.; Leiser, R.; Schams, D.; Dantzer, V. Localization of Vascular Endothelial Growth Factor (VEGF) and Its Receptors VEGFR-1 and VEGFR-2 in Bovine Placentomes from Implantation until Term. Placenta 2006, 27, 889–898. [Google Scholar] [CrossRef]
  50. Złotkowska, A.; Adamczyk, S.; Andronowska, A. Presence of Trophoblast in the Uterine Lumen Affects VEGF-C Expression in Porcine Endometrium. Theriogenology 2019, 125, 216–223. [Google Scholar] [CrossRef]
  51. Hunter, M.G.; Robinson, R.S.; Mann, G.E.; Webb, R. Endocrine and Paracrine Control of Follicular Development and Ovulation Rate in Farm Species. Anim. Reprod. Sci. 2004, 82–83, 461–477. [Google Scholar] [CrossRef]
  52. Anchordoquy, J.M.; Anchordoquy, J.P.; Testa, J.A.; Sirini, M.Á.; Furnus, C.C. Influence of Vascular Endothelial Growth Factor and Cysteamine on in Vitro Bovine Oocyte Maturation and Subsequent Embryo Development. Cell Biol. Int. 2015, 39, 1090–1098. [Google Scholar] [CrossRef]
  53. Biswas, D.; So, K.H.; Hwang, S.U.; Yoon, J.D.; Kim, M.; Kim, D.Y.; Hyun, S.H. Embryotropic Effects of Vascular Endothelial Growth Factor on Porcine Embryos Produced by in Vitro Fertilization. Theriogenology 2018, 120, 147–156. [Google Scholar] [CrossRef] [PubMed]
  54. Liu, X.; Hao, Y.; Li, Z.; Zhou, J.; Zhu, H.; Bu, G.; Liu, Z.; Hou, X.; Zhang, X.; Miao, Y.-L. Maternal Cytokines CXCL12, VEGFA, and WNT5A Promote Porcine Oocyte Maturation via MAPK Activation and Canonical WNT Inhibition. Front. Cell Dev. Biol. 2020, 8, 578. [Google Scholar] [CrossRef] [PubMed]
  55. Guimarães, G.C.; Alves, L.A.; Betarelli, R.P.; Guimarães, C.S.O.; Helmo, F.R.; Pereira Júnior, C.D.; Corrêa, R.R.M.; Zangeronimo, M.G. Expression of Vascular Endothelial Growth Factor (VEGF) and Factor VIII in the Gilt Placenta and Its Relation to Fetal Development. Theriogenology 2017, 92, 63–68. [Google Scholar] [CrossRef] [PubMed]
  56. Chiumia, D.; Hankele, A.-K.; Groebner, A.E.; Schulke, K.; Reichenbach, H.-D.; Giller, K.; Zakhartchenko, V.; Bauersachs, S.; Ulbrich, S.E. Vascular Endothelial Growth Factor A and VEGFR-1 Change during Preimplantation in Heifers. Int. J. Mol. Sci. 2020, 21, 544. [Google Scholar] [CrossRef] [Green Version]
  57. Mess, A.M.; Carreira, A.C.O.; Marinovic de Oliveira, C.; Fratini, P.; Favaron, P.O.; Barreto, R. da S.N.; Pfarrer, C.; Meirelles, F.V.; Miglino, M.A. Vascularization and VEGF Expression Altered in Bovine Yolk Sacs from IVF and NT Technologies. Theriogenology 2017, 87, 290–297. [Google Scholar] [CrossRef]
  58. Berisha, B.; Schams, D.; Kosmann, M.; Amselgruber, W.; Einspanier, R. Expression and Tissue Concentration of Vascular Endothelial Growth Factor, Its Receptors, and Localization in the Bovine Corpus Luteum during Estrous Cycle and Pregnancy. Biol. Reprod. 2000, 63, 1106–1114. [Google Scholar] [CrossRef]
  59. Sugino, N.; Suzuki, T.; Sakata, A.; Miwa, I.; Asada, H.; Taketani, T.; Yamagata, Y.; Tamura, H. Angiogenesis in the Human Corpus Luteum: Changes in Expression of Angiopoietins in the Corpus Luteum throughout the Menstrual Cycle and in Early Pregnancy. J. Clin. Endocrinol. Metab. 2005, 90, 6141–6148. [Google Scholar] [CrossRef] [Green Version]
  60. Wheeler, K.C.; Jena, M.K.; Pradhan, B.S.; Nayak, N.; Das, S.; Hsu, C.-D.; Wheeler, D.S.; Chen, K.; Nayak, N.R. VEGF May Contribute to Macrophage Recruitment and M2 Polarization in the Decidua. PLoS ONE 2018, 13, e0191040. [Google Scholar] [CrossRef] [PubMed]
  61. Hedger, M.P.; Winnall, W.R.; Phillips, D.J.; de Kretser, D.M. The Regulation and Functions of Activin and Follistatin in Inflammation and Immunity. Vitam Horm. 2011, 85, 255–297. [Google Scholar] [CrossRef]
  62. Akpan, I.; Pro, B.; Platanias, L.C. Transforming Growth Factor Superfamily Ligands and Links to Tumorigenesis. Leuk Lymphoma 2018, 59, 1282–1283. [Google Scholar] [CrossRef] [PubMed]
  63. Bloise, E.; Ciarmela, P.; Dela Cruz, C.; Luisi, S.; Petraglia, F.; Reis, F.M. Activin A in Mammalian Physiology. Physiol. Rev. 2019, 99, 739–780. [Google Scholar] [CrossRef] [PubMed]
  64. Paria, B.C.; Dey, S.K. Preimplantation Embryo Development in Vitro: Cooperative Interactions among Embryos and Role of Growth Factors. Proc. Natl. Acad. Sci. USA 1990, 87, 4756–4760. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Pauken, C.M.; Capco, D.G. Regulation of Cell Adhesion during Embryonic Compaction of Mammalian Embryos: Roles for PKC and Beta-Catenin. Mol. Reprod. Dev. 1999, 54, 135–144. [Google Scholar] [CrossRef]
  66. Yoon, J.D.; Hwang, S.-U.; Kim, M.; Lee, G.; Jeon, Y.; Hyun, S.-H. GDF8 Enhances SOX2 Expression and Blastocyst Total Cell Number in Porcine IVF Embryo Development. Theriogenology 2019, 129, 70–76. [Google Scholar] [CrossRef]
  67. Jaeger, L.A.; Spiegel, A.K.; Ing, N.H.; Johnson, G.A.; Bazer, F.W.; Burghardt, R.C. Functional Effects of Transforming Growth Factor Beta on Adhesive Properties of Porcine Trophectoderm. Endocrinology 2005, 146, 3933–3942. [Google Scholar] [CrossRef] [Green Version]
  68. Hajian, M.; Hosseini, S.M.; Ostadhosseini, S.; Nasr-Esfahani, M.H. Targeting the Transforming Growth Factor-β Signaling during Pre-Implantation Development in Embryos of Cattle, Sheep and Goats. Growth Factors 2016, 34, 141–148. [Google Scholar] [CrossRef]
  69. Sudiman, J.; Sutton-McDowall, M.L.; Ritter, L.J.; White, M.A.; Mottershead, D.G.; Thompson, J.G.; Gilchrist, R.B. Bone Morphogenetic Protein 15 in the Pro-Mature Complex Form Enhances Bovine Oocyte Developmental Competence. PLoS ONE 2014, 9, e103563. [Google Scholar] [CrossRef] [Green Version]
  70. Barrera, A.D.; García, E.V.; Miceli, D.C. Effect of Exogenous Transforming Growth Factor Β1 (TGF-Β1) on Early Bovine Embryo Development. Zygote 2018, 26, 232–241. [Google Scholar] [CrossRef]
  71. Weiss, A.; Attisano, L. The TGFbeta Superfamily Signaling Pathway. Wiley Interdiscip Rev. Dev. Biol. 2013, 2, 47–63. [Google Scholar] [CrossRef]
  72. Zhang, K.; Rajput, S.K.; Lee, K.-B.; Wang, D.; Huang, J.; Folger, J.K.; Knott, J.G.; Zhang, J.; Smith, G.W. Evidence Supporting a Role for SMAD2/3 in Bovine Early Embryonic Development: Potential Implications for Embryotropic Actions of Follistatin. Biol. Reprod. 2015, 93, 86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Ashry, M.; Rajput, S.K.; Folger, J.K.; Knott, J.G.; Hemeida, N.A.; Kandil, O.M.; Ragab, R.S.; Smith, G.W. Functional Role of AKT Signaling in Bovine Early Embryonic Development: Potential Link to Embryotrophic Actions of Follistatin. Reprod. Biol. Endocrinol. 2018, 16, 1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Böttcher, R.T.; Niehrs, C. Fibroblast Growth Factor Signaling during Early Vertebrate Development. Endocr. Rev. 2005, 26, 63–77. [Google Scholar] [CrossRef] [PubMed]
  75. Cooke, F.N.T.; Pennington, K.A.; Yang, Q.; Ealy, A.D. Several Fibroblast Growth Factors Are Expressed during Pre-Attachment Bovine Conceptus Development and Regulate Interferon-Tau Expression from Trophectoderm. Reproduction 2009, 137, 259–269. [Google Scholar] [CrossRef] [Green Version]
  76. Michael, D.D.; Alvarez, I.M.; Ocón, O.M.; Powell, A.M.; Talbot, N.C.; Johnson, S.E.; Ealy, A.D. Fibroblast Growth Factor-2 Is Expressed by the Bovine Uterus and Stimulates Interferon-Tau Production in Bovine Trophectoderm. Endocrinology 2006, 147, 3571–3579. [Google Scholar] [CrossRef] [Green Version]
  77. Ocón-Grove, O.M.; Cooke, F.N.T.; Alvarez, I.M.; Johnson, S.E.; Ott, T.L.; Ealy, A.D. Ovine Endometrial Expression of Fibroblast Growth Factor (FGF) 2 and Conceptus Expression of FGF Receptors during Early Pregnancy. Domest. Anim. Endocrinol. 2008, 34, 135–145. [Google Scholar] [CrossRef]
  78. Dichmann, D.S.; Miller, C.P.; Jensen, J.; Scott Heller, R.; Serup, P. Expression and Misexpression of Members of the FGF and TGFbeta Families of Growth Factors in the Developing Mouse Pancreas. Dev. Dyn. 2003, 226, 663–674. [Google Scholar] [CrossRef]
  79. Hillege, M.M.G.; Galli Caro, R.A.; Offringa, C.; de Wit, G.M.J.; Jaspers, R.T.; Hoogaars, W.M.H. TGF-β Regulates Collagen Type I Expression in Myoblasts and Myotubes via Transient Ctgf and Fgf-2 Expression. Cells 2020, 9, 375. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  80. Moore, J.W.; Dionne, C.; Jaye, M.; Swain, J.L. The MRNAs Encoding Acidic FGF, Basic FGF and FGF Receptor Are Coordinately Downregulated during Myogenic Differentiation. Development 1991, 111, 741–748. [Google Scholar] [CrossRef]
  81. Nishimura, T.; Nakatake, Y.; Konishi, M.; Itoh, N. Identification of a Novel FGF, FGF-21, Preferentially Expressed in the Liver. Biochim Biophys Acta 2000, 1492, 203–206. [Google Scholar] [CrossRef]
  82. Soulet, L.; Chevet, E.; Lemaitre, G.; Blanquaert, F.; Meddahi, A.; Barritault, D. FGFs and Their Receptors, in Vitro and in Vivo Studies: New FGF Receptor in the Brain, FGF-1 in Muscle, and the Use of Functional Analogues of Low-Affinity Heparin-Binding Growth Factor Receptors in Tissue Repair. Mol. Reprod. Dev. 1994, 39, 49–54, discussion 54–55. [Google Scholar] [CrossRef]
  83. Zhang, Y.; Madiai, F.; Hackshaw, K.V. Cloning and Characterization of a Novel Form of Mouse Fibroblast Growth Factor-1 (FGF-1) MRNA, FGF-1.G: Differential Expression of FGF-1 and FGF-1.G MRNAs during Embryonic Development and in Postnatal Tissues. Biochim. Biophys. Acta 2001, 1521, 45–58. [Google Scholar] [CrossRef]
  84. Yang, L.; Soonpaa, M.H.; Adler, E.D.; Roepke, T.K.; Kattman, S.J.; Kennedy, M.; Henckaerts, E.; Bonham, K.; Abbott, G.W.; Linden, R.M.; et al. Human Cardiovascular Progenitor Cells Develop from a KDR+ Embryonic-Stem-Cell-Derived Population. Nature 2008, 453, 524–528. [Google Scholar] [CrossRef] [PubMed]
  85. Yook, J.-Y.; Kim, M.-J.; Son, M.J.; Lee, S.; Nam, Y.; Han, Y.-M.; Cho, Y.S. Combinatorial Activin Receptor-like Kinase/Smad and Basic Fibroblast Growth Factor Signals Stimulate the Differentiation of Human Embryonic Stem Cells into the Cardiac Lineage. Stem Cells Dev. 2011, 20, 1479–1490. [Google Scholar] [CrossRef] [PubMed]
  86. Guzzetta, A.; Koska, M.; Rowton, M.; Sullivan, K.R.; Jacobs-Li, J.; Kweon, J.; Hidalgo, H.; Eckart, H.; Hoffmann, A.D.; Back, R.; et al. Hedgehog-FGF Signaling Axis Patterns Anterior Mesoderm during Gastrulation. Proc. Natl. Acad. Sci. USA 2020, 117, 15712–15723. [Google Scholar] [CrossRef]
  87. Kunath, T.; Yamanaka, Y.; Detmar, J.; MacPhee, D.; Caniggia, I.; Rossant, J.; Jurisicova, A. Developmental Differences in the Expression of FGF Receptors between Human and Mouse Embryos. Placenta 2014, 35, 1079–1088. [Google Scholar] [CrossRef]
  88. Taniguchi, F.; Harada, T.; Iwabe, T.; Ohama, Y.; Takenaka, Y.; Terakawa, N. Aberrant Expression of Keratinocyte Growth Factor Receptor in Ovarian Surface Epithelial Cells of Endometrioma. Fertil. Steril. 2008, 89, 478–480. [Google Scholar] [CrossRef] [PubMed]
  89. Barros, R.G.; Lima, P.F.; Soares, A.C.S.; Sanches, L.; Price, C.A.; Buratini, J. Fibroblast Growth Factor 2 Regulates Cumulus Differentiation under the Control of the Oocyte. J. Assist. Reprod. Genet. 2019, 36, 905–913. [Google Scholar] [CrossRef]
  90. Diógenes, M.N.; Guimarães, A.L.S.; Leme, L.O.; Dode, M.A.N. Bovine in Vitro Embryo Production: The Effects of Fibroblast Growth Factor 10 (FGF10). J. Assist. Reprod. Genet. 2017, 34, 383–390. [Google Scholar] [CrossRef] [Green Version]
  91. Mor, A.; Mondal, S.; Reddy, I.J.; Nandi, S.; Gupta, P. Molecular Cloning and Expression of FGF2 Gene in Pre-Implantation Developmental Stages of in Vitro-Produced Sheep Embryos. Reprod. Domest. Anim. 2018, 53, 895–903. [Google Scholar] [CrossRef] [PubMed]
  92. Pan, Y.; Wang, M.; Baloch, A.R.; Zhang, Q.; Wang, J.; Ma, R.; Xu, G.; Kashif, J.; Wang, L.; Fan, J.; et al. FGF10 Enhances Yak Oocyte Fertilization Competence and Subsequent Blastocyst Quality and Regulates the Levels of CD9, CD81, DNMT1, and DNMT3B. J. Cell Physiol. 2019, 234, 17677–17689. [Google Scholar] [CrossRef]
  93. Da Silva, R.B.; Yang, M.Y.; Caixeta, E.S.; Castilho, A.C.; Amorim, R.L.; Price, C.A.; Fortune, J.E.; Buratini, J. Fibroblast Growth Factor 18 Regulates Steroidogenesis in Fetal Bovine Ovarian Tissue in Vitro. Mol. Reprod. Dev. 2019, 86, 166–174. [Google Scholar] [CrossRef] [PubMed]
  94. Akizawa, H.; Nagatomo, H.; Odagiri, H.; Kohri, N.; Yamauchi, N.; Yanagawa, Y.; Nagano, M.; Takahashi, M.; Kawahara, M. Conserved Roles of Fibroblast Growth Factor Receptor 2 Signaling in the Regulation of Inner Cell Mass Development in Bovine Blastocysts. Mol. Reprod. Dev. 2016, 83, 516–525. [Google Scholar] [CrossRef]
  95. Valdez Magaña, G.; Rodríguez, A.; Zhang, H.; Webb, R.; Alberio, R. Paracrine Effects of Embryo-Derived FGF4 and BMP4 during Pig Trophoblast Elongation. Dev. Biol. 2014, 387, 15–27. [Google Scholar] [CrossRef] [PubMed]
  96. Madiai, F.; Hackshaw, K. Expression of the Mouse FGF-1 and FGF-1.A MRNAs during Embryonic Development and in the Aging Heart. Res. Commun. Mol. Pathol. Pharmacol. 2002, 112, 139–144. [Google Scholar]
  97. Ferriani, R.A.; Ahmed, A.; Sharkey, A.; Smith, S.K. Colocalization of Acidic and Basic Fibroblast Growth Factor (FGF) in Human Placenta and the Cellular Effects of BFGF in Trophoblast Cell Line JEG-3. Growth Factors 1994, 10, 259–268. [Google Scholar] [CrossRef] [PubMed]
  98. Wang, Y.-S.; Li, J.-Y.; Jin, S.-H.; Wang, H.-Y. The expression of basic fibroblast growth factor 1 during human embryonic yolk sac hematopoiesis. Zhonghua Xue Ye Xue Za Zhi 2008, 29, 535–539. [Google Scholar]
  99. Fu, Y.M.; Spirito, P.; Yu, Z.X.; Biro, S.; Sasse, J.; Lei, J.; Ferrans, V.J.; Epstein, S.E.; Casscells, W. Acidic Fibroblast Growth Factor in the Developing Rat Embryo. J. Cell Biol. 1991, 114, 1261–1273. [Google Scholar] [CrossRef] [Green Version]
  100. Gupta, A.; Bazer, F.W.; Jaeger, L.A. Immunolocalization of Acidic and Basic Fibroblast Growth Factors in Porcine Uterine and Conceptus Tissues. Biol. Reprod. 1997, 56, 1527–1536. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Niswander, L.; Martin, G.R. Fgf-4 Expression during Gastrulation, Myogenesis, Limb and Tooth Development in the Mouse. Development 1992, 114, 755–768. [Google Scholar] [CrossRef] [PubMed]
  102. Laufer, E.; Nelson, C.E.; Johnson, R.L.; Morgan, B.A.; Tabin, C. Sonic Hedgehog and Fgf-4 Act through a Signaling Cascade and Feedback Loop to Integrate Growth and Patterning of the Developing Limb Bud. Cell 1994, 79, 993–1003. [Google Scholar] [CrossRef]
  103. Pizette, S.; Coulier, F.; Birnbaum, D.; DeLapeyrière, O. FGF6 Modulates the Expression of Fibroblast Growth Factor Receptors and Myogenic Genes in Muscle Cells. Exp. Cell Res. 1996, 224, 143–151. [Google Scholar] [CrossRef]
  104. Pfarrer, C.; Weise, S.; Berisha, B.; Schams, D.; Leiser, R.; Hoffmann, B.; Schuler, G. Fibroblast Growth Factor (FGF)-1, FGF2, FGF7 and FGF Receptors Are Uniformly Expressed in Trophoblast Giant Cells during Restricted Trophoblast Invasion in Cows. Placenta 2006, 27, 758–770. [Google Scholar] [CrossRef]
  105. Cormier, S.; Leroy, C.; Delezoide, A.-L.; Silve, C. Expression of Fibroblast Growth Factors 18 and 23 during Human Embryonic and Fetal Development. Gene Expr. Patterns 2005, 5, 569–573. [Google Scholar] [CrossRef]
  106. Rinderknecht, E.; Humbel, R.E. The Amino Acid Sequence of Human Insulin-like Growth Factor I and Its Structural Homology with Proinsulin. J. Biol. Chem. 1978, 253, 2769–2776. [Google Scholar] [CrossRef]
  107. Roberts, C.T.; Owens, J.A.; Sferruzzi-Perri, A.N. Distinct Actions of Insulin-like Growth Factors (IGFs) on Placental Development and Fetal Growth: Lessons from Mice and Guinea Pigs. Placenta 2008, 29 (Suppl. A), S42–S47. [Google Scholar] [CrossRef] [PubMed]
  108. Germain-Lee, E.L.; Janicot, M.; Lammers, R.; Ullrich, A.; Casella, S.J. Expression of a Type I Insulin-like Growth Factor Receptor with Low Affinity for Insulin-like Growth Factor II. Biochem. J. 1992, 281 Pt 2, 413–417. [Google Scholar] [CrossRef] [Green Version]
  109. Ullrich, A.; Gray, A.; Tam, A.W.; Yang-Feng, T.; Tsubokawa, M.; Collins, C.; Henzel, W.; Le Bon, T.; Kathuria, S.; Chen, E. Insulin-like Growth Factor I Receptor Primary Structure: Comparison with Insulin Receptor Suggests Structural Determinants That Define Functional Specificity. EMBO J. 1986, 5, 2503–2512. [Google Scholar] [CrossRef]
  110. Liu, J.P.; Baker, J.; Perkins, A.S.; Robertson, E.J.; Efstratiadis, A. Mice Carrying Null Mutations of the Genes Encoding Insulin-like Growth Factor I (Igf-1) and Type 1 IGF Receptor (Igf1r). Cell 1993, 75, 59–72. [Google Scholar] [CrossRef]
  111. Charnock, J.C.; Dilworth, M.R.; Aplin, J.D.; Sibley, C.P.; Westwood, M.; Crocker, I.P. The Impact of a Human IGF-II Analog ([Leu27]IGF-II) on Fetal Growth in a Mouse Model of Fetal Growth Restriction. Am. J. Physiol. Endocrinol. Metab. 2016, 310, E24–E31. [Google Scholar] [CrossRef] [Green Version]
  112. Fan, B.; Onteru, S.K.; Du, Z.-Q.; Garrick, D.J.; Stalder, K.J.; Rothschild, M.F. Genome-Wide Association Study Identifies Loci for Body Composition and Structural Soundness Traits in Pigs. PLoS ONE 2011, 6, e14726. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Ouni, M.; Gunes, Y.; Belot, M.-P.; Castell, A.-L.; Fradin, D.; Bougnères, P. The IGF1 P2 Promoter Is an Epigenetic QTL for Circulating IGF1 and Human Growth. Clin. Epigenetics 2015, 7, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Spiroski, A.M.; Oliver, M.H.; Jaquiery, A.L.; Prickett, T.C.R.; Espiner, E.A.; Harding, J.E.; Bloomfield, F.H. Postnatal Effects of Intrauterine Treatment of the Growth-Restricted Ovine Fetus with Intra-Amniotic Insulin-like Growth Factor-1. J. Physiol. 2018, 596, 5925–5945. [Google Scholar] [CrossRef] [Green Version]
  115. Sutter, N.B.; Bustamante, C.D.; Chase, K.; Gray, M.M.; Zhao, K.; Zhu, L.; Padhukasahasram, B.; Karlins, E.; Davis, S.; Jones, P.G.; et al. A Single IGF1 Allele Is a Major Determinant of Small Size in Dogs. Science 2007, 316, 112–115. [Google Scholar] [CrossRef] [Green Version]
  116. Clemmons, D.R.; Maile, L.A. Interaction between Insulin-like Growth Factor-I Receptor and AlphaVbeta3 Integrin Linked Signaling Pathways: Cellular Responses to Changes in Multiple Signaling Inputs. Mol. Endocrinol. 2005, 19, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Kitamura, T.; Kahn, C.R.; Accili, D. Insulin Receptor Knockout Mice. Annu. Rev. Physiol. 2003, 65, 313–332. [Google Scholar] [CrossRef]
  118. Ipsa, E.; Cruzat, V.F.; Kagize, J.N.; Yovich, J.L.; Keane, K.N. Growth Hormone and Insulin-Like Growth Factor Action in Reproductive Tissues. Front. Endocrinol. 2019, 10, 777. [Google Scholar] [CrossRef]
  119. Lighten, A.D.; Hardy, K.; Winston, R.M.L.; Moore, G.E. Expression of MRNA for the Insulin-like Growth Factors and Their Receptors in Human Preimplantation Embryos. Mol. Reprod. Dev. 1997, 47, 134–139. [Google Scholar] [CrossRef]
  120. Ozden-Akkaya, O.; Altunbas, K.; Yagcı, A. Effects of Methoxychlor on IGF-I Signaling Pathway in Rat Ovary. Biotech. Histochem. 2017, 92, 230–242. [Google Scholar] [CrossRef]
  121. Giroto, A.B.; Fontes, P.K.; Franchi, F.F.; Dos Santos, P.H.; Razza, E.M.; Nogueira, M.F.G.; Maioli, M.A.; Nogueira, G.P.; Nunes, G.B.; Mingoti, G.Z.; et al. Use of Pregnancy-Associated Plasma Protein-A during Oocyte in Vitro Maturation Increases IGF-1 and Affects the Transcriptional Profile of Cumulus Cells and Embryos from Nelore Cows. Mol. Reprod. Dev. 2019, 86, 1694–1704. [Google Scholar] [CrossRef] [PubMed]
  122. Lopes, A.C.; Palhão, M.P.; Fernandes, C.; Sudano, M.J.; Castilho, A.; Caixeta, E.S. Differential Expression of Insulin-like Growth Factor Family Members in Immature Cumulus-Oocyte Complexes from Dairy Cows with Different Genotypes. Reprod. Domest. Anim. 2017, 52, 1067–1073. [Google Scholar] [CrossRef] [PubMed]
  123. Balogh, O.; Müller, L.; Boos, A.; Kowalewski, M.P.; Reichler, I.M. Expression of Insulin-like Growth Factor 1 and Its Receptor in Preovulatory Follicles and in the Corpus Luteum in the Bitch. Gen. Comp. Endocrinol. 2018, 269, 68–74. [Google Scholar] [CrossRef] [PubMed]
  124. Herrick, J.R.; Greene-Ermisch, A.F.; Schoolcraft, W.B.; Krisher, R.L. Exogenous Growth Factors Do Not Affect the Development of Individually Cultured Murine Embryos. J. Assist. Reprod. Genet. 2018, 35, 523–531. [Google Scholar] [CrossRef] [PubMed]
  125. Javvaji, P.K.; Dhali, A.; Francis, J.R.; Kolte, A.P.; Roy, S.C.; Selvaraju, S.; Mech, A.; Sejian, V. IGF-1 Treatment during in Vitro Maturation Improves Developmental Potential of Ovine Oocytes through the Regulation of PI3K/Akt and Apoptosis Signaling. Anim. Biotechnol. 2020, 1–8. [Google Scholar] [CrossRef]
  126. Rodrigues, T.A.; Ispada, J.; Risolia, P.H.B.; Rodrigues, M.T.; Lima, R.S.; Assumpção, M.E.O.A.; Visintin, J.A.; Paula-Lopes, F.F. Thermoprotective Effect of Insulin-like Growth Factor 1 on in Vitro Matured Bovine Oocyte Exposed to Heat Shock. Theriogenology 2016, 86, 2028–2039. [Google Scholar] [CrossRef]
  127. Bonometti, S.; Menarim, B.C.; Reinholt, B.M.; Ealy, A.D.; Johnson, S.E. Growth Factor Modulation of Equine Trophoblast Mitosis and Prostaglandin Gene Expression. J. Anim. Sci. 2019, 97, 865–873. [Google Scholar] [CrossRef]
  128. Wamaitha, S.E.; Grybel, K.J.; Alanis-Lobato, G.; Gerri, C.; Ogushi, S.; McCarthy, A.; Mahadevaiah, S.K.; Healy, L.; Lea, R.A.; Molina-Arcas, M.; et al. IGF1-Mediated Human Embryonic Stem Cell Self-Renewal Recapitulates the Embryonic Niche. Nat. Commun. 2020, 11, 764. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  129. Ghanipoor-Samami, M.; Javadmanesh, A.; Burns, B.M.; Thomsen, D.A.; Nattrass, G.S.; Estrella, C.A.S.; Kind, K.L.; Hiendleder, S. Atlas of Tissue- and Developmental Stage Specific Gene Expression for the Bovine Insulin-like Growth Factor (IGF) System. PLoS ONE 2018, 13, e0200466. [Google Scholar] [CrossRef]
  130. Sessions-Bresnahan, D.R.; Heuberger, A.L.; Carnevale, E.M. Obesity in Mares Promotes Uterine Inflammation and Alters Embryo Lipid Fingerprints and Homeostasis. Biol. Reprod. 2018, 99, 761–772. [Google Scholar] [CrossRef]
  131. Zhang, J.-J.; Liu, X.; Chen, L.; Zhang, S.; Zhang, X.; Hao, C.; Miao, Y.-L. Advanced Maternal Age Alters Expression of Maternal Effect Genes That Are Essential for Human Oocyte Quality. Aging (Albany N. Y.) 2020, 12, 3950–3961. [Google Scholar] [CrossRef]
  132. Liu, H.C.; He, Z.Y.; Mele, C.A.; Veeck, L.L.; Davis, O.; Rosenwaks, Z. Human Endometrial Stromal Cells Improve Embryo Quality by Enhancing the Expression of Insulin-like Growth Factors and Their Receptors in Cocultured Human Preimplantation Embryos. Fertil. Steril. 1999, 71, 361–367. [Google Scholar] [CrossRef]
  133. Kowalik, A.; Liu, H.C.; He, Z.Y.; Mele, C.; Barmat, L.; Rosenwaks, Z. Expression of the Insulin-like Growth Factor-1 Gene and Its Receptor in Preimplantation Mouse Embryos; Is It a Marker of Embryo Viability? Mol. Hum. Reprod. 1999, 5, 861–865. [Google Scholar] [CrossRef] [PubMed]
  134. Korgun, E.T.; Dohr, G.; Desoye, G.; Demir, R.; Kayisli, U.A.; Hahn, T. Expression of Insulin, Insulin-like Growth Factor I and Glucocorticoid Receptor in Rat Uterus and Embryo during Decidualization, Implantation and Organogenesis. Reproduction 2003, 125, 75–84. [Google Scholar] [CrossRef] [PubMed]
  135. Lonergan, P.; Gutiérrez-Adán, A.; Pintado, B.; Fair, T.; Ward, F.; Fuente, J.D.L.; Boland, M. Relationship between Time of First Cleavage and the Expression of IGF-I Growth Factor, Its Receptor, and Two Housekeeping Genes in Bovine Two-Cell Embryos and Blastocysts Produced in Vitro. Mol. Reprod. Dev. 2000, 57, 146–152. [Google Scholar] [CrossRef]
  136. Watson, A.J.; Watson, P.H.; Arcellana-Panlilio, M.; Warnes, D.; Walker, S.K.; Schultz, G.A.; Armstrong, D.T.; Seamark, R.F. A Growth Factor Phenotype Map for Ovine Preimplantation Development. Biol. Reprod. 1994, 50, 725–733. [Google Scholar] [CrossRef] [Green Version]
  137. Guo, X.; Yang, D.; Ao, X.; Wu, X.; Li, G.; Wang, L.; Bao, M.-T.; Xue, L.; Bou, S. Production of Transgenic Cashmere Goat Embryos Expressing Red Fluorescent Protein and Containing IGF1 Hair-Follicle-Cell Specific Expression Cassette by Somatic Cell Nuclear Transfer. Sci. China C Life Sci. 2009, 52, 390–397. [Google Scholar] [CrossRef]
  138. Kautz, E.; Gram, A.; Aslan, S.; Ay, S.S.; Selçuk, M.; Kanca, H.; Koldaş, E.; Akal, E.; Karakaş, K.; Findik, M.; et al. Expression of Genes Involved in the Embryo-Maternal Interaction in the Early-Pregnant Canine Uterus. Reproduction 2014, 147, 703–717. [Google Scholar] [CrossRef] [Green Version]
  139. Pandey, S.P.; Chandel, H.S.; Srivastava, S.; Selvaraj, S.; Jha, M.K.; Shukla, D.; Ebensen, T.; Guzman, C.A.; Saha, B. Pegylated Bisacycloxypropylcysteine, a Diacylated Lipopeptide Ligand of TLR6, Plays a Host-Protective Role against Experimental Leishmania Major Infection. J. Immunol. 2014, 193, 3632–3643. [Google Scholar] [CrossRef]
  140. Huang, B.; Ning, S.; Zhang, Q.; Chen, A.; Jiang, C.; Cui, Y.; Hu, J.; Li, H.; Fan, G.; Qin, L.; et al. Bisphenol A Represses Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells through Downregulating the Expression of Insulin-like Growth Factor 1. Mol. Neurobiol. 2017, 54, 3798–3812. [Google Scholar] [CrossRef]
  141. Yucel Cicek, O.S.; Hekimoglu, E.R.; Turgal, M.; Atilla, P.; Cakar, A.N.; Usubutun, A.; Beksac, M.S. Differential Expression of Leukemia Inhibitory Factor and Insulin like Growth Factor-1 between Normal Pregnancies, Partial Hydatidiform Moles and Complete Hydatidiform Moles. Placenta 2018, 69, 64–70. [Google Scholar] [CrossRef] [PubMed]
  142. Zhang, X.; Kidder, G.M.; Watson, A.J.; Schultz, G.A.; Armstrong, D.T. Possible Roles of Insulin and Insulin-like Growth Factors in Rat Preimplantation Development: Investigation of Gene Expression by Reverse Transcription-Polymerase Chain Reaction. J. Reprod. Fertil. 1994, 100, 375–380. [Google Scholar] [CrossRef] [Green Version]
  143. Bartolac, L.K.; Lowe, J.L.; Koustas, G.; Grupen, C.G.; Sjöblom, C. Vitrification, Not Cryoprotectant Exposure, Alters the Expression of Developmentally Important Genes in in Vitro Produced Porcine Blastocysts. Cryobiology 2018, 80, 70–76. [Google Scholar] [CrossRef] [PubMed]
  144. Hernández, R.; Rodríguez, F.M.; Gareis, N.C.; Rey, F.; Barbeito, C.G.; Diessler, M.E. Abundance of Insulin-like Growth Factors 1 and 2, and Type 1 Insulin-like Growth Factor Receptor in Placentas of Dogs. Anim. Reprod. Sci. 2020, 221, 106554. [Google Scholar] [CrossRef] [PubMed]
  145. Ma, W.; Huang, X.; Yang, X.; Liang, X. Maternal Obesity in Mice Not Only Affects Fresh Embryo Quality but Also Aggravates Injury Due to Vitrification. J. Assist. Reprod. Genet. 2016, 33, 1515–1523. [Google Scholar] [CrossRef] [Green Version]
  146. Wang, L.M.; Feng, H.L.; Ma, Y.Z.; Cang, M.; Li, H.J.; Yan, Z.; Zhou, P.; Wen, J.X.; Bou, S.; Liu, D.J. Expression of IGF Receptors and Its Ligands in Bovine Oocytes and Preimplantation Embryos. Anim. Reprod. Sci. 2009, 114, 99–108. [Google Scholar] [CrossRef]
  147. Han, V.K.; Bassett, N.; Walton, J.; Challis, J.R. The Expression of Insulin-like Growth Factor (IGF) and IGF-Binding Protein (IGFBP) Genes in the Human Placenta and Membranes: Evidence for IGF-IGFBP Interactions at the Feto-Maternal Interface. J. Clin. Endocrinol. Metab. 1996, 81, 2680–2693. [Google Scholar] [CrossRef]
  148. Agaoglu, O.K.; Agaoglu, A.R.; Guzeloglu, A.; Aslan, S.; Kurar, E.; Kayis, S.A.; Schäfer-Somi, S. Gene Expression Profiles of Some Cytokines, Growth Factors, Receptors, and Enzymes (GM-CSF, IFNγ, MMP-2, IGF-II, EGF, TGF-β, IGF-IIR) during Pregnancy in the Cat Uterus. Theriogenology 2016, 85, 638–644. [Google Scholar] [CrossRef]
  149. Waurich, R.; Ringleb, J.; Braun, B.C.; Jewgenow, K. Embryonic Gene Activation in in Vitro Produced Embryos of the Domestic Cat (Felis Catus). Reproduction 2010, 140, 531–540. [Google Scholar] [CrossRef]
  150. Schultz, G.A.; Hogan, A.; Watson, A.J.; Smith, R.M.; Heyner, S. Insulin, Insulin-like Growth Factors and Glucose Transporters: Temporal Patterns of Gene Expression in Early Murine and Bovine Embryos. Reprod. Fertil. Dev. 1992, 4, 361–371. [Google Scholar] [CrossRef] [PubMed]
  151. Ramin, N.; Thieme, R.; Fischer, S.; Schindler, M.; Schmidt, T.; Fischer, B.; Navarrete Santos, A. Maternal Diabetes Impairs Gastrulation and Insulin and IGF-I Receptor Expression in Rabbit Blastocysts. Endocrinology 2010, 151, 4158–4167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  152. Arat, S.; Caputcu, A.T.; Cevik, M.; Akkoc, T.; Cetinkaya, G.; Bagis, H. Effect of Growth Factors on Oocyte Maturation and Allocations of Inner Cell Mass and Trophectoderm Cells of Cloned Bovine Embryos. Zygote 2016, 24, 554–562. [Google Scholar] [CrossRef] [PubMed]
  153. Chen, P.; Pan, Y.; Cui, Y.; Wen, Z.; Liu, P.; He, H.; Li, Q.; Peng, X.; Zhao, T.; Yu, S. Insulin-like Growth Factor I Enhances the Developmental Competence of Yak Embryos by Modulating Aquaporin 3. Reprod. Domest. Anim. 2017, 52, 825–835. [Google Scholar] [CrossRef] [PubMed]
  154. Conceição, J.C.Z.; Moura, M.T.; Ferreira-Silva, J.C.; Cantanhêde, L.F.; Chaves, R.M.; Lima, P.F.; Oliveira, M.A.L. Incidence of Apoptosis after Retinoids and Insulin-like Growth Factor-I (IGF-I) Supplementation during Goat in Vitro Embryo Production. Zygote 2016, 24, 808–813. [Google Scholar] [CrossRef] [PubMed]
  155. Kelly, J.M.; Kleemann, D.O.; Maxwell, W.M.C.; Walker, S.K. Effects of Insulin-like Growth Factor-I, Epidermal Growth Factor and Cysteamine on the in Vitro Maturation and Development of Oocytes Collected from 6- to 8-Week-Old Merino Lambs. Reprod. Fertil. Dev. 2008, 20, 570–578. [Google Scholar] [CrossRef]
  156. Liu, H.-B.; Muhammad, T.; Guo, Y.; Li, M.-J.; Sha, Q.-Q.; Zhang, C.-X.; Liu, H.; Zhao, S.-G.; Zhao, H.; Zhang, H.; et al. RNA-Binding Protein IGF2BP2/IMP2 Is a Critical Maternal Activator in Early Zygotic Genome Activation. Adv. Sci. 2019, 6, 1900295. [Google Scholar] [CrossRef] [Green Version]
  157. Valleh, M.V.; Tahmoorespur, M.; Joupari, M.D.; Dehghani, H.; Rasmussen, M.A.; Hyttel, P.; Strøbech, L. Paternal Breed Effects on Expression of IGF-II, BAK1 and BCL2-L1 in Bovine Preimplantation Embryos. Zygote 2015, 23, 712–721. [Google Scholar] [CrossRef] [Green Version]
  158. Harris, L.K.; Pantham, P.; Yong, H.E.J.; Pratt, A.; Borg, A.J.; Crocker, I.; Westwood, M.; Aplin, J.; Kalionis, B.; Murthi, P. The Role of Insulin-like Growth Factor 2 Receptor-Mediated Homeobox Gene Expression in Human Placental Apoptosis, and Its Implications in Idiopathic Fetal Growth Restriction. Mol. Hum. Reprod. 2019, 25, 572–585. [Google Scholar] [CrossRef]
  159. Citri, A.; Yarden, Y. EGF-ERBB Signalling: Towards the Systems Level. Nat. Rev. Mol. Cell Biol. 2006, 7, 505–516. [Google Scholar] [CrossRef]
  160. Richani, D.; Gilchrist, R.B. The Epidermal Growth Factor Network: Role in Oocyte Growth, Maturation and Developmental Competence. Hum. Reprod. Update 2018, 24, 1–14. [Google Scholar] [CrossRef] [Green Version]
  161. Da Rosa, P.R.A.; De Cesaro, M.P.; Pereira Dau, A.M.; Duggavathi, R.; Bordignon, V.; Gonçalves, P.B.D. Reversible Meiotic Arrest of Bovine Oocytes by EGFR Inhibition and Follicular Hemisections. Theriogenology 2017, 99, 53–62. [Google Scholar] [CrossRef] [PubMed]
  162. Sugimura, S.; Yamanouchi, T.; Palmerini, M.G.; Hashiyada, Y.; Imai, K.; Gilchrist, R.B. Effect of Pre-in Vitro Maturation with CAMP Modulators on the Acquisition of Oocyte Developmental Competence in Cattle. J. Reprod. Dev. 2018, 64, 233–241. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  163. Saraiva, M.V.A.; Rossetto, R.; Brito, I.R.; Celestino, J.J.H.; Silva, C.M.G.; Faustino, L.R.; Almeida, A.P.; Bruno, J.B.; Magalhães, D.M.; Matos, M.H.T.; et al. Dynamic Medium Produces Caprine Embryo from Preantral Follicles Grown in Vitro. Reprod. Sci. 2010, 17, 1135–1143. [Google Scholar] [CrossRef] [PubMed]
  164. Wasielak, M.; Więsak, T.; Bogacka, I.; Jalali, B.M.; Bogacki, M. Maternal Effect Gene Expression in Porcine Metaphase II Oocytes and Embryos in Vitro: Effect of Epidermal Growth Factor, Interleukin-1β and Leukemia Inhibitory Factor. Zygote 2017, 25, 120–130. [Google Scholar] [CrossRef]
  165. Mesalam, A.; Lee, K.-L.; Khan, I.; Chowdhury, M.M.R.; Zhang, S.; Song, S.-H.; Joo, M.-D.; Lee, J.-H.; Jin, J.-I.; Kong, I.-K. A Combination of Bovine Serum Albumin with Insulin-Transferrin-Sodium Selenite and/or Epidermal Growth Factor as Alternatives to Fetal Bovine Serum in Culture Medium Improves Bovine Embryo Quality and Trophoblast Invasion by Induction of Matrix Metalloproteinases. Reprod. Fertil. Dev. 2019, 31, 333–346. [Google Scholar] [CrossRef]
  166. Chediek Dall’Acqua, P.; Barros Nunes, G.; Rodrigues da Silva, C.; Fontes, P.K.; Fábio Gouveia Nogueira, M.; Lombardi Lopes, F.; Marinho, M.; Zoccal Mingoti, G. Differences in Embryonic Gene Expression and Quality Indicate the Benefit of Epidermal Growth Factor Receptor Inhibitor during Prematuration to Improve Competence in Bovine Oocytes. Reprod. Domest. Anim. 2019, 54, 666–677. [Google Scholar] [CrossRef] [PubMed]
  167. Cheng, E.-H.; Liu, J.-Y.; Lee, T.-H.; Huang, C.-C.; Chen, C.-I.; Huang, L.-S.; Lee, M.-S. Requirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling Pathways. PLoS ONE 2016, 11, e0153086. [Google Scholar] [CrossRef] [PubMed]
  168. Park, K.-M.; Wang, J.W.; Yoo, Y.-M.; Choi, M.J.; Hwang, K.C.; Jeung, E.-B.; Jeong, Y.W.; Hwang, W.S. Sphingosine-1-Phosphate (S1P) Analog Phytosphingosine-1-Phosphate (P1P) Improves the in Vitro Maturation Efficiency of Porcine Oocytes via Regulation of Oxidative Stress and Apoptosis. Mol. Reprod. Dev. 2019, 86, 1705–1719. [Google Scholar] [CrossRef]
  169. Flores, J.M.; Sánchez, M.A.; García, P.; Sánchez, B.; Nieto, A. Immunohistochemical Localization of Epidermal Growth Factor, Transforming Growth Factor-Alpha and Growth Factor-Beta s in the Caprine Peri-Implantation Period. Theriogenology 1998, 50, 931–944. [Google Scholar] [CrossRef]
  170. Gharib-Hamrouche, N.; Chêne, N.; Guillomot, M.; Martal, J. Localization and Characterization of EGF/TGF-Alpha Receptors on Peri-Implantation Trophoblast in Sheep. J. Reprod. Fertil. 1993, 98, 385–392. [Google Scholar] [CrossRef] [Green Version]
  171. Jeong, W.; Jung, S.; Bazer, F.W.; Song, G.; Kim, J. Epidermal Growth Factor: Porcine Uterine Luminal Epithelial Cell Migratory Signal during the Peri-Implantation Period of Pregnancy. Mol. Cell Endocrinol. 2016, 420, 66–74. [Google Scholar] [CrossRef]
  172. Takeuchi, M.; Seki, M.; Furukawa, E.; Takahashi, A.; Saito, K.; Kobayashi, M.; Ezoe, K.; Fukui, E.; Yoshizawa, M.; Matsumoto, H. Improvement of Implantation Potential in Mouse Blastocysts Derived from IVF by Combined Treatment with Prolactin, Epidermal Growth Factor and 4-Hydroxyestradiol. Mol. Hum. Reprod. 2017, 23, 557–570. [Google Scholar] [CrossRef] [PubMed]
  173. Crispo, M.; Dos Santos-Neto, P.C.; Vilariño, M.; Mulet, A.P.; de León, A.; Barbeito, L.; Menchaca, A. RAPID COMMUNICATION: Nerve Growth Factor Influences Cleavage Rate and Embryo Development in Sheep. J. Anim. Sci. 2016, 94, 4447–4451. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  174. Garcia-Garcia, R.M.; Arias-Alvarez, M.; Sanchez-Rodriguez, A.; Lorenzo, P.L.; Rebollar, P.G. Role of Nerve Growth Factor in the Reproductive Physiology of Female Rabbits: A Review. Theriogenology 2020, 150, 321–328. [Google Scholar] [CrossRef] [PubMed]
  175. Garfield, A.S.; Cowley, M.; Smith, F.M.; Moorwood, K.; Stewart-Cox, J.E.; Gilroy, K.; Baker, S.; Xia, J.; Dalley, J.W.; Hurst, L.D.; et al. Distinct Physiological and Behavioural Functions for Parental Alleles of Imprinted Grb10. Nature 2011, 469, 534–538. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. Wu, X.; Song, M.; Yang, X.; Liu, X.; Liu, K.; Jiao, C.; Wang, J.; Bai, C.; Su, G.; Liu, X.; et al. Establishment of Bovine Embryonic Stem Cells after Knockdown of CDX2. Sci. Rep. 2016, 6, 28343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  177. Gómez, E.; Carrocera, S.; Martin, D.; Sánchez-Calabuig, M.J.; Gutiérrez-Adán, A.; Murillo, A.; Muñoz, M. Hepatoma-Derived Growth Factor: Protein Quantification in Uterine Fluid, Gene Expression in Endometrial-Cell Culture and Effects on in Vitro Embryo Development, Pregnancy and Birth. Theriogenology 2017, 96, 118–125. [Google Scholar] [CrossRef]
  178. Hong, L.; He, Y.; Tan, C.; Wu, Z.; Yu, M. HAI-1 Regulates Placental Folds Development by Influencing Trophoblast Cell Proliferation and Invasion in Pigs. Gene 2020, 749, 144721. [Google Scholar] [CrossRef] [PubMed]
  179. Kohama, K.; Kawaguchi, M.; Fukushima, T.; Lin, C.-Y.; Kataoka, H. Regulation of Pericellular Proteolysis by Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) in Trophoblast Cells. Hum. Cell 2012, 25, 100–110. [Google Scholar] [CrossRef]
  180. Robertson, S.A.; Sjöblom, C.; Jasper, M.J.; Norman, R.J.; Seamark, R.F. Granulocyte-Macrophage Colony-Stimulating Factor Promotes Glucose Transport and Blastomere Viability in Murine Preimplantation Embryos. Biol. Reprod. 2001, 64, 1206–1215. [Google Scholar] [CrossRef] [Green Version]
  181. Larson, R.C.; Ignotz, G.G.; Currie, W.B. Platelet Derived Growth Factor (PDGF) Stimulates Development of Bovine Embryos during the Fourth Cell Cycle. Development 1992, 115, 821–826. [Google Scholar] [CrossRef] [PubMed]
  182. Thibodeaux, J.K.; Del Vecchio, R.P.; Hansel, W. Role of Platelet-Derived Growth Factor in Development of in Vitro Matured and in Vitro Fertilized Bovine Embryos. J. Reprod. Fertil. 1993, 98, 61–66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  183. Kawamura, K.; Chen, Y.; Shu, Y.; Cheng, Y.; Qiao, J.; Behr, B.; Pera, R.A.R.; Hsueh, A.J.W. Promotion of Human Early Embryonic Development and Blastocyst Outgrowth in Vitro Using Autocrine/Paracrine Growth Factors. PLoS ONE 2012, 7, e49328. [Google Scholar] [CrossRef] [Green Version]
  184. Jannaman, E.A.; Xiao, Y.; Hansen, P.J. Actions of Colony-Stimulating Factor 3 on the Maturing Oocyte and Developing Embryo in Cattle. J. Anim. Sci. 2020, 98, skaa115. [Google Scholar] [CrossRef] [PubMed]
Vetsci 08 00078 g001 550
Figure 1. Timing of development after fertilization from a zygote to implantation in different species of mammals [1,11,12,13].
Figure 1. Timing of development after fertilization from a zygote to implantation in different species of mammals [1,11,12,13].
Vetsci 08 00078 g001
Vetsci 08 00078 g002 550
Figure 2. Schematic of the canonical pathway of apoptosis regulation by signaling of the IGF system. IGF-1 binds to insulin-like growth factor receptor 1 (IGFR-1); IGF-2 binds to IGFR-1, IGFR-2, and insulin receptor (IR), and two factors activate the PI3K/AKT pathway, up- and down-regulating expression of anti-apoptotic and apoptotic genes, respectively.
Figure 2. Schematic of the canonical pathway of apoptosis regulation by signaling of the IGF system. IGF-1 binds to insulin-like growth factor receptor 1 (IGFR-1); IGF-2 binds to IGFR-1, IGFR-2, and insulin receptor (IR), and two factors activate the PI3K/AKT pathway, up- and down-regulating expression of anti-apoptotic and apoptotic genes, respectively.
Vetsci 08 00078 g002
Table
Table 1. More important fibroblast growth factor (FGF) family members related to reproduction events, localization in embryos, and the species in which they are found.
Table 1. More important fibroblast growth factor (FGF) family members related to reproduction events, localization in embryos, and the species in which they are found.
FGF Family MemberLocalizationSpecies
FGF-1MesodermMouse [96]
Late embryo (Day 12.5)Mouse [82]
TrophectodermHuman [97]
MesodermHuman [98]
MesodermRat [99]
TrophectodermCattle [74]
FGF-2TrophectodermHuman [97]
MesodermRat [99]
TrophectodermCattle [74]
EctodermPig [100]
MesodermPig [100]
EndodermPig [100]
FGF-4ICMMouse [101]
FGF-6SomitesMouse [102]
MyoblastsMouse [103]
FGF-7TrophectodermCow [104]
FGF-10TrophectodermCattle [75]
Teca cellsHuman [88]
FGF-18Late embryo (Day 30)Human [105]
FGF-23Late embryo (Day 30)Human [105]
Table
Table 2. Spatiotemporal expression of insulin-like growth factors (IGFs) across mammalian species.
Table 2. Spatiotemporal expression of insulin-like growth factors (IGFs) across mammalian species.
IGF System CompoundLocalizationSpecies
IGF-1BlastocystHuman [132], mouse [133], rat [134], cattle [135], sheep [136], goat [137], rabbit [48], dog [138], buffalo [139]
Early embryoHuman [140], cattle [129], horse [130]
Early placenta or pregnant endometriumHuman [141], rat [142], rabbit [48], pig [143], dog [144], horse [127]
IGF-2BlastocystHuman [119], mouse [145], rat [142], cattle [146], sheep [137], pig [143], rabbit [48], goat [22], dog [138], horse [130], buffalo [139]
Early embryoCattle [129]
Early placenta or pregnant endometriumHuman [147], rat [142], rabbit [48], dog [144], cat [148]
IGFR-1BlastocystHuman [119], mouse [133], rat [134], cattle [135], sheep [136], rabbit [48], horse [130], cat [149], buffalo [139]
Early embryoCattle [129]
Early placenta or pregnant endometriumDog [144], rabbit [48], rat [134]
IGFR-2BlastocystHuman [119], rat [134], cattle [146], pig [143], goat [22], rabbit [48], cat [149], horse [130], buffalo [139]
Early embryoCattle [129]
Early placenta or pregnant endometriumRabbit [48], cat [148]
IRBlastocystHuman [119], mouse [150], rat [134], rabbit [151], cattle [150], sheep [136]
Early embryoCattle [129]
Early placenta or pregnant endometriumRat [134]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Llobat, L. Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach. Vet. Sci. 2021, 8, 78. https://doi.org/10.3390/vetsci8050078

AMA Style

Llobat L. Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach. Veterinary Sciences. 2021; 8(5):78. https://doi.org/10.3390/vetsci8050078

Chicago/Turabian Style

Llobat, Lola. 2021. "Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach" Veterinary Sciences 8, no. 5: 78. https://doi.org/10.3390/vetsci8050078

APA Style

Llobat, L. (2021). Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach. Veterinary Sciences, 8(5), 78. https://doi.org/10.3390/vetsci8050078

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop